Application no. and date | 17851614.2 (espacenet) (Federated) (European Patent Register), 20170915 | Patent/reg. no. and date | DK/EP 3512506, 20220126 | Publication date | 20190724 | Priority no. and date | US 201662395854 P, 20160916 | EP pub. no. and date |
EP 3512506 20190724 | Effective date | | Applicant/owner | Prilenia Neurotherapeutics Ltd., 10 HaMenofim Street
Herzliya 4672561, IL | Applicant ref. no. | 13708 | Inventor | HAYDEN, Michael, c/o 5 Basel Street P.O. Box 3190
49131 Petach-Tikva, IL, GEVA, Michal, Rozmarin 5 P.O.Box 7253
Even-Yehuda, IL, LAUFER, Ralph, Shenkin 55
6523309 Tel Aviv, IL | Representative | COSMOVICI INTELLECTUAL PROPERTY, Rue de la Corraterie 5
1204 Geneva, CH | Opponent | | IPC Class | A61K 31/451 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) , A61K 9/48 (2006.01) , A61P 21/00 (2006.01) | Title | ANVENDELSE AF PRIDOPIDIN TIL BEHANDLING AF RETTS SYNDROM | Int. application no. | US2017051803 | Int. publication no. | WO2018053280 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|